In the Original Investigation titled “Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study,”1 published in the December 2015 issue of JAMA Oncology, the conflict of interest disclosure statement in the Article Information section was incomplete. The original statement was “Dr Sutphen has received personal fees from InformedDNA outside the present work. No other disclosures are reported.” This should have been “Dr Sutphen received payment for serving as President and Chief Medical Officer of InformedDNA, which provides a network of genetics specialists and a library of genetic tests and hereditary conditions. No other disclosures are reported.” The article has been corrected online.
et al. Utilization and outcomes of BRCA
genetic testing and counseling in a national commercially insured population: the ABOUT Study. JAMA Oncol
. 2015;1(9):1251-1260.PubMedGoogle ScholarCrossref